The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

by Aude Legoffic, Ezequiel Calvo, Carla Cano, Emma Folch-Puy, Marc Barthet, Jean Robert Delpero, Montse Ferrés-Masó, Jean Charles Dagorn, Daniel Closa, Juan Iovanna
Published 2009-10-01